TGFB1 and cancer: Activated TGFβ pathway equips cancer cells with increased migration capability by inducing EMT process, where it decreases the expression of epithelial markers such as E-cadherin and increases the expression of mesenchymal markers like N-cadherin and vimentin4,5.